- - , /PRNewswire/ -- T1D Exchange, a nonprofit organization that drives meaningful research and improvement in care and outcomes in type 1 and type 2 diabetes, today announced that new research using real-world data from its Quality Improvement Collaborative (T1DX-QI) and online patient Registry will be shared in nine oral and 12 poster presentations during the 84th Scientific Sessions being held , in . The studies detail trends and outcomes in the management of diabetes, including the importance of collaboration to close gaps and improve outcomes, the off-label use of glucagon-like peptide-1 (GLP-1) in people with type 1 diabetes (T1D), and varying characteristics and symptoms among users of continuous glucose monitors (CGMs). For a second consecutive year, T1D Exchange was selected for an ADA Presidents' Select Abstract, and this year the oral presentation is titled "Dynamics of Treatment Regimens and Glycemic Outcomes in >100,000 Children from International Pediatrics Diabetes Registries.
" A full list of abstracts can be found . "We're thrilled to share compelling research utilizing data from our core programs, the Quality Improvement Collaborative and patient Registry, both of which continue to grow," said . "Our expanded research capabilities and comprehensive patient data can generate novel insights to help partners improve products and care delivery.
" Additionally, data from 12 studies will be presented during the General Poster Sessions on , and , at in the Poster Ha.
